Table 2. Serum antibody titers against pandemic virus CA04.
| CA04-specific HIa | |||
| animal | H1N1pdm prechallenge | day 7 post-H1N1pdm | day 21 post-H1N1pdm |
| rh2306 | <8b | <10 | 160 |
| r01072 | <8 | <10 | 80 |
| r02027 | <8 | <10 | 160 |
| r02108 | <8 | <10 | 160 |
| r03079 | <8 | <10 | 160 |
| r02002 | <8 | <10 | 640 |
| r03087 | <8 | <10 | 320 |
| r03089 | <8 | <10 | 320 |
| r03137 | <8 | <10 | 320 |
| r04052 | <8 | <10 | 320 |
| r04077 | <8 | <10 | 320 |
| r05092 | <8 | <10 | 160 |
a
serum HI titers against pandemic virus A/California/04/2009 bHI assays conducted using turkey red blood cells and animal serum with pandemic virus CA04. Detection limit 8 or 10, depending on lowest serum concentration tested.